PubMed Health⌕ Search

Biomedical subjects

V Bruni

Publications and source records attributed to V Bruni.

52 records · Page 3Linked to original sources
PubMedDate not supplied

The MPA test: a reevaluation.

The response to the administration of Medroxy-progesterone Acetate (MPA) is nowadays widely employed as an indirect index of oestrogen level in women with secondary amenorrhea. The Authors studied the relationship between the response to the MPA test and the activity of the Hypothalamic-pituitary-ovarian axis: they also compared the MPA test with other endocrinological investigations, such as the GnRH and Clomiphene citrate tests. Furthermore, MPA was compared to Noretisterone acetate and to rectally administered pure Progesterone in order to ascertain their pharmacodynamic features.

Amenorrhea↗
PubMedDate not supplied

Increased thrombin generation in normal pregnancy.

The aim of this longitudinal study was to evaluate whether an increased thrombin generation takes place in normal pregnancy by determining fibronopeptide A plasma concentration in 24 women at three stages of gestation. The activity of the main blood clotting inhibitors, antithrombin III and protein C., and platelet agregability were also investigated. Our study showed a significant rise of fibrinopeptide A plasma levels already manifest at the first trimester. Antithrombin III activity was found to slightly but significantly decrease during pregnancy, whereas protein C levels showed a moderate, significant increase. A slight platelet activation was observed in the second and third trimester. These findings indicate that during pregnancy a new equilibrium of blood clotting system arises, shifted to a hypercoagulable state which leads to the increased risk of thromboembolism observed in pregnancy.

Adult↗
PubMedDate not supplied

Chronic phospholipid liposomes administration and ovarian function.

In the past years, hypothalamic phospholipids (H-PL) have been used therapeutically for their behavioral effects. The major pharmacological effect of H-PLs is that they increase the turnover rate of biogenic amines in the brain. Previous studies have also shown that a single i.v. dose of H-PL may influence tha plasma levels of gonadotropins, prolactin (PRL) and growth hormone (GH). Since data have not yet been published concerning the effects, if any, of chronic i.m. administration of H-PL on the ovarian function, the present study was undertaken to gain insight into this issue. Four women were studied. Each subject was given H-PLs by i.m. injection from the 5th to the 20th day of the cycle at the dose of 100 mg/day. Blood samples were repeatedly taken over this period to measure the plasma concentrations of FSH, LH, E2, PRL, and progesterone. GH administration, no side-effects were noted in any of the subjects studied. All subjects presented normal plasma levels of FSH, LH, E2, PRL, and progesterone. GH demonstrated some upward fluctuations, which always regressed rapidly. Our findings demonstrate that chronic H-PL administration at therapeutic doses does not influence the ovarian cycle in women. In the light of our data, it appears that different hormonal effects are elicited by a single i.v. high-dose administration of H-PLs as compared with those produced by chronic i.m. treatment at therapeutic doses.

Adult↗